Pasithea Therapeutics Management
Management criteria checks 4/4
Pasithea Therapeutics' CEO is Tiago Marques, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is $537.35K, comprised of 83.7% salary and 16.3% bonuses, including company stock and options. directly owns 3.07% of the company’s shares, worth $120.38K. The average tenure of the management team and the board of directors is 3 years and 3.1 years respectively.
Key information
Tiago Marques
Chief executive officer
US$537.3k
Total compensation
| CEO salary percentage | 83.7% |
| CEO tenure | 4.3yrs |
| CEO ownership | 3.1% |
| Management average tenure | 3yrs |
| Board average tenure | 3.1yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$16m |
| Jun 30 2024 | n/a | n/a | -US$16m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$537k | US$450k | -US$16m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$15m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$539k | US$450k | -US$12m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$4m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | US$672k | US$244k | -US$2m |
Compensation vs Market: Tiago's total compensation ($USD537.35K) is about average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Tiago's compensation has been consistent with company performance over the past year.
CEO
Tiago Marques (47 yo)
4.3yrs
Tenure
US$537,347
Compensation
Dr. Tiago Reis Marques, M. D., Ph. D., has been the Chief Executive Officer and Director at Pasithea Therapeutics Corp. since August 2020. He is a senior clinical fellow at Imperial College London and a le...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.3yrs | US$250.00k | 5.24% $ 205.7k | |
| CEO & Director | 4.3yrs | US$537.35k | 3.07% $ 120.4k | |
| Chief Financial Officer | 2.1yrs | US$345.94k | 0% $ 0 | |
| Chief Development Officer | 2.4yrs | US$444.86k | 0% $ 0 | |
| COO & Head of UK Clinics | 3.7yrs | no data | no data |
3.0yrs
Average Tenure
47yo
Average Age
Experienced Management: KTTA's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.3yrs | US$250.00k | 5.24% $ 205.7k | |
| CEO & Director | 4.3yrs | US$537.35k | 3.07% $ 120.4k | |
| Independent Director | 2.2yrs | US$50.00k | 0.28% $ 10.9k | |
| Independent Director | 3.4yrs | US$60.00k | 0% $ 0 | |
| Member of Scientific Advisory Board | 2.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.6yrs | US$60.00k | 0.20% $ 7.8k | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
3.1yrs
Average Tenure
57yo
Average Age
Experienced Board: KTTA's board of directors are considered experienced (3.1 years average tenure).